Price T Rowe Associates Inc Igm Biosciences, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IGMS
# of Institutions
90Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$28.1 Million0.5% of portfolio
-
Artal Group S.A. Luxembourg, N43.08MShares$21.2 Million1.6% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$21.1 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$8.78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA854KShares$5.86 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $199M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...